Navigation Links
Amgen Donates $1 Million to Help Japanese Disaster Victims
Date:3/14/2011

THOUSAND OAKS, Calif., March 14, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that the company will donate $1 million to Japanese disaster relief efforts.  Amgen and the Amgen Foundation will distribute the funds to both Direct Relief International and International Medical Corps to bring basic needs and vital health services to those affected in Japan.

Amgen has a long history in Japan with our partnership with Kirin Holding and its pharmaceutical affiliate Kyowa Hakko Kirin that began in 1984, and more recently partnerships with Takeda Pharmaceuticals and Daiichi Sankyo.

"The earthquake and subsequent tsunami in Japan have been devastating to so many people throughout the country," said Kevin Sharer, Amgen's chairman and chief executive officer. "Our sincere sympathy goes to all of those in Japan affected by this tragedy."

Amgen has selected the two organizations for their capacity and experience to respond to large-scale disaster relief efforts. Since its inception 60 years ago, Direct Relief has provided medical assistance to improve the quality of life for people affected by poverty, disaster, and civil unrest at home and throughout the world. International Medical Corps is a global, humanitarian, nonprofit organization dedicated to saving lives and relieving suffering through health care training and relief and development programs.

About AmgenAmgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amgen Completes Acquisition of BioVex
2. NBPTS and Amgen Foundation Join to Bolster Science Education
3. Amgen to Present at the Citi 2011 Global Healthcare Conference
4. CURE Magazine Teams Up With Amgen Oncology and Breakaway from Cancer® to Launch 2011 Extraordinary Healer Award for Oncology Nursing
5. Boehringer Ingelheim to Purchase Amgens Fremont (USA) Facility
6. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
7. Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive
8. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
9. MedImmune In-Licenses Clinical-Stage Anti-Inflammatory Monoclonal Antibody From Amgen
10. Amgen to Present at the 29th Annual JP Morgan Healthcare Conference
11. Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... and sale of patented biopharmaceutical medicine, modernized traditional Chinese ... today announced the business and development progress at its ... Following the September 2014 JCM application (No. 51268) for ...
(Date:1/22/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a ... cardiovascular disease and overall health is pleased to provide you ... its outlook for 2015 from the CEO, Mr. Eugene ... would like to take this opportunity to share with you ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Infectious Disease Diagnostics Market by Product, Application, Technology, ... to their offering. , The infectious disease ... 7.9% to reach $18,156.2 million by 2019 from $12,422.8 ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... today announced positive results from a Phase 1 trial ... in vitro anti-pseudomonal activity. The results from ... well tolerated, with a clinical and laboratory safety profile ... toxicity was observed, even at the highest dose regimen ...
... 23 Each year in the United States more than ... These new cases account for 10 percent of the new ... several types of leukemia, the survival rate has not changed ... Golubieski, president of Foundation Venture Capital Group, LLC, a New ...
Cached Medicine Technology:Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity 2Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments 2
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... an effort to further promote visibility and adoption of the ... made AMA journals available via its subscription services, EBSCO will ... , Long known as both a subscription agency ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... Simply selecting brown rice over white also makes a difference, ... rice is better than white rice at reducing the risk ... effective at lowering the risk, study findings show. , U.S. ... Follow-up Study and 157,463 women in the Nurses, Health Study ...
... test might cut unnecessary biopsies, researchers say , WEDNESDAY, ... in finding ways to treat and detect stubborn forms ... three studies being presented this week at the annual ... include cancers of the prostate, kidney, bladder and testicles," ...
... but turn to physicians for final decisions, survey shows , ... vast amounts of health information available to the general public, ... than ever to trust their doctor with medical decisions, a ... more you need the physician to help you decipher that ...
... , ... ... ... ...
... ... ... , ... , , , , ...
... rejection in kidney transplant recipients while better preserving ... data from two international phase III clinical trials ... March issue of the American Journal of ... the paper describing BENEFIT (Belatacept Evaluation of Nephroprotection ...
Cached Medicine News:Health News:Whole Grains Take a Bite Out of Type 2 Diabetes Risk 2Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 2Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 3Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 4Health News:People Still Trust Their Doctors Rather Than the Internet 2Health News:People Still Trust Their Doctors Rather Than the Internet 3Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 2Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 3Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 4Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 5Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 6Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 7Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 8Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 9Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 10Health News:Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results 11Health News:Obama Proposes Health Care Bill Fully Funding Abortion 2Health News:Obama Proposes Health Care Bill Fully Funding Abortion 3Health News:Transplant drug preserves kidneys, avoids toxicity 2
The compact PT stepper is lightweight, user-friendly, and versatile. The perfect solution for a busy brachytherapy facility....
... Each Prospera® brachytherapy source consists of a ... Palladium-103 adsorbed onto four resin beads. ... gold beads which serve as x-ray markers ... Prospera sources are supplied non-sterile when ...
... Using ion implantation to manufacture ... proprietary method buries pure isotopes of ... of the seed core matrix material. ... the inventory of seed cores in ...
... The UroVysion Bladder Cancer Kit (UroVysion Kit) is ... 17, and loss of the 9p21 locus via ... from persons with hematuria suspected of having bladder ... for use, in conjunction with and not in ...
Medicine Products: